Devin Gattey, MD
Ophthalmology · Aloha, ORNPI 1194776484
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (40.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 51.0% of the total. Reporting peaked in 2019 at $2,257 and has fallen 95.0% since, to $112 in 2025.
Across 34 payments — averaging $132.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$2K
- Eli Lilly$2K
- Alcon$619
- Lombart Brothers, Inc.$45
- Aerie Pharmaceuticals, Inc.$19
- Sun Pharmaceutical Industries Inc.$14
- plus $11 from 1 others
What the payments were for
- Consulting fees$1,50033%
- Travel & lodging$1,82240%
- Food & beverage$1,18326%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 9 | $2,297 |
| Eli Lilly | 3 | $1,500 |
| Alcon | 18 | $619 |
| Lombart Brothers, Inc. | 1 | $45 |
| Aerie Pharmaceuticals, Inc. | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Carl Zeiss Meditec USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis 1-piece IOL$2,142
- Tecnis 3-piece IOL$2,142
- Tecnis Symphony IOL$2,142
- Tecnis Symphony Toric IOL$2,142
- Clareon PanOptix Pro$112
How this compares
$4,505 in reported general payments places this provider in the 85th percentile of 248 ophthalmology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 37 | $32,784 |
| LumiganBimatoprost | 15 | $10,712 |
| Cyclosporine | 15 | $7,533 |
| VyzultaLatanoprostene Bunod | 17 | $7,136 |
| Latanoprost | 412 | $6,291 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 151 | $3,025 |
| Timolol Maleate | 168 | $2,394 |
| Prednisolone Acetate | 58 | $2,126 |
| Ketorolac Tromethamine | 41 | $979 |
| Dorzolamide Hcl | 42 | $861 |
| Brimonidine Tartrate | 62 | $761 |
| Ofloxacin | 39 | $477 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 21 | $352 |
| Levobunolol Hcl | 11 | $348 |
| ErythromycinErythromycin Base | 13 | $151 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Aloha
- David HuangCorvallis$67K
- Mark PennesiPortland$56K
- Rene ChoiPortland$21K
- Balamurali AmbatiEugene$19K
- Richard HoffmanEugene$17K
- Bart AdamsPendleton$17K
- Richard WeleberPortland$14K
- Aazim SiddiquiPortland$13K
- Kurt AndreasonBend$13K
- Poorav PatelMedford$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.